News

We are looking to find out how readers are expecting the market to perform into 2010, what will be the key sectors, trends and spending areas, and where

The US Food and Drug Administration (USFDA) has approved Indus Biotech to conduct clinical trails for its molecule, IND02, reported The Economic Times. The newly developed molecule is

Romaco has presented the vertical heat-sealing machine – Siebler HM 1/230 – for strip-packaging of pharmaceutical solids such as tablets, capsules and effervescent tablets at P-MEC 2009. The

Genmab has reached a milestone for Arzerra (ofatumumab) under the terms of its collaboration with GlaxoSmithKline (GSK). A milestone payment of approximately $23m was triggered by the FDA

The FDA has reviewed and has allowed the use of twelve new structural health claims filed for Algatechnologies’ AstaPure brand of natural astaxanthin in the US market. Reportedly,

Pursuant to the terms of the agreement, Sequenom agreed to grant Ibis Biosciences and its affiliates, including Abbott Laboratories, a non-exclusive license under the three mass spectrometry-based patents

King Pharmaceuticals (King) has licensed from Merck Sante, an affiliate of Germany-based Merck KGaA, the exclusive rights to market and sell Cyanokit 5g (hydroxocobalamin for injection) Antidote in

Sinovac Biotech has received third purchase order for its H1N1 vaccine, PANFLU.1, from China’s Ministry of Industry and Information Technology for the national stockpiling plan. Under the purchase

GlaxoSmithKline (GSK) has announced that approximately half a million people will receive its pandemic H1N1 vaccine, Pandemrix, as part of Government initiated vaccination programs across Europe, this week.